This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Vyvanse 40 mg capsules. The contract has a ceiling value of $9,227.86 and a performance period ending on August 8, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Vyvanse 20 mg capsules. The contract has a ceiling value of $4,065.21 and runs through January 23, 2025. It is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 30 mg capsules. The total ceiling value of the contract is $1,348.00, with a final completion date of September 22, 2023. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 40 mg Vyvanse capsules. The contract has a ceiling value of $1,292.02 and an ultimate completion date of September 11, 2024. This award is not associated with a set-aside program. AmerisourceBergen will be supplying the Vyvanse medication, a prescription drug used to treat ADHD, to support various military treatment facilities and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 30 mg capsules. The contract is a firm fixed-price delivery order with a ceiling value of $9,680.28 and an ultimate completion date of August 28, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,112.36 and is for the delivery of Vyvanse 20 mg capsules. The contract is a Firm Fixed Price delivery order contract with an ultimate completion date of June 5, 2024. The contract was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse (lisdexamfetamine dimesylate) 50 mg capsules. The contract has a ceiling value of $2,851.42 and a completion date of August 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Vyvanse 20 mg capsules. The order has a ceiling value of $14,202.77 and a completion date of September 11, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 20 mg capsules. The contract has a ceiling value of $4,405.36 and a completion date of October 15, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide the DLA with this critical pharmaceutical product to support the healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,975.52 firm-fixed-price contract is for the delivery of Vyvanse 50 mg capsules. The contract has an ultimate completion date of July 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical division, valued at up to $999,999,999 through December 2025, for...